Eli Lilly and Co.'s necitumumab injection, in combination with gemcitabine and cisplatin, for first-line treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer
Read MoreJUL 9 ODAC BS
Eli Lilly and Co.'s necitumumab injection, in combination with gemcitabine and cisplatin, for first-line treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer
Read MoreJUL 9 ODAC
Eli Lilly and Co.'s necitumumab injection, in combination with gemcitabine and cisplatin, for first-line treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer
Read MoreJUL 9 ODAC
Eli Lilly and Co.'s necitumumab injection, in combination with gemcitabine and cisplatin, for first-line treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer
Read More